Pfizer

16. Okt. 2026, 20:07 UTC

Pfizer Inc shares are modestly higher, having peaked earlier in the day, and remain notably above their 20-day moving average following three consecutive daily gains.

15. Okt. 2026, 23:06 UTC

Pfizer Inc shares are trading slightly lower in after-market hours, fluctuating around Thursday's close after experiencing a notable dip earlier in the session.

14. Okt. 2026, 23:41 UTC

Pfizer Inc. shares are trading higher in after-market hours, rebounding after an initial dip and remaining above its 20-day moving average.

13. Okt. 2026, 20:08 UTC

Pfizer Inc announced a research collaboration and license agreement with Enodia Therapeutics, potentially exceeding $500 million, to develop sec61-targeting small molecules.

12. Okt. 2026, 20:07 UTC

Pfizer Inc shares are modestly higher, hovering near the upper end of their one-month range and above the 20-day moving average.

9. Okt. 2026, 23:05 UTC

Pfizer Inc. is trading roughly flat in after-hours activity, remaining around the middle of its one-month range since Friday's close.

8. Okt. 2026, 23:20 UTC

Pfizer Inc. shares declined in after-market trading, showing unusual weakness and reaching a low return of nearly 0.3% before a slight recovery.

7. Okt. 2026, 20:01 UTC

Pfizer Inc. shares rose after FDA approval of TUKYSA for HER2-positive metastatic breast cancer, following positive Phase 3 trial results and consistent safety data.

6. Okt. 2026, 22:50 UTC

Pfizer Inc. saw a modest increase in after-market trading, recovering from a low point but remains below its 20-day moving average.

5. Okt. 2026, 20:06 UTC

Pfizer shares fell sharply to a six-week low as the Florida Attorney General filed a lawsuit alleging the company misled consumers about its COVID-19 vaccine's safety.

2. Okt. 2026, 20:01 UTC

Pfizer Inc. shares fell despite positive Phase 3 trial results for LITFULO in nonsegmental vitiligo, with the stock below its 20-day moving average.

1. Okt. 2026, 20:07 UTC

Pfizer's shares fell amid a lawsuit from Florida's Attorney General alleging deceptive marketing of its COVID-19 vaccine, seeking $10K fines per violation.

30. Sept. 2026, 19:51 UTC

Pfizer Inc. shares fell modestly as the Pharmaceuticals sub-sector declined, influenced by Eli Lilly's stock drop following its TRIUMPH-2 trial results.

29. Sept. 2026, 20:07 UTC

Pfizer Inc is set to present data from 45 research abstracts at the ESMO Congress in October 2026, while shares are trading roughly flat.

28. Sept. 2026, 19:16 UTC

Pfizer Inc. shares are higher as the company prepares to present 45 abstracts at the European Society for Medical Oncology Congress from October 23-27, 2026.

25. Sept. 2026, 23:05 UTC

Pfizer Inc. is trading lower in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

24. Sept. 2026, 23:06 UTC

Pfizer Inc. is trading lower in after-market hours, reflecting broader market declines amid ongoing geopolitical tensions and economic concerns.

23. Sept. 2026, 20:07 UTC

Pfizer Inc is modestly higher, continuing a trend of gains over the past three sessions, as the broader market also shows positive performance.

22. Sept. 2026, 23:01 UTC

Pfizer Inc. is declining in after-market trading, moving lower from Tuesday's close and nearing the lower end of its one-month trading range.

21. Sept. 2026, 23:06 UTC

Pfizer Inc. is seeing a modest increase in after-market trading, following a flat session, as economic growth indicators suggest continued accommodative monetary policy.

18. Sept. 2026, 23:51 UTC

Pfizer Inc is trading lower in after-market hours, reflecting a decline since Friday's close, influenced by Bristol-Myers Squibb's recent performance.

17. Sept. 2026, 22:51 UTC

Pfizer Inc. is gaining modestly in after-market trading, influenced by fluctuations and the performance of Bristol-Myers Squibb's Phase 3 study results.

16. Sept. 2026, 20:10 UTC

Pfizer Inc faces social media scrutiny over its drug pipeline needs, contributing to a decline despite exceeding revenue and earnings expectations.

15. Sept. 2026, 23:02 UTC

Pfizer Inc. shares are roughly flat in after-market trading amid broader market sentiment affected by a decline in the New York Empire State Manufacturing Index.

14. Sept. 2026, 23:01 UTC

Pfizer Inc shares are lower in after-market hours, with no specific news identified. Broader market declines are linked to rising crude oil prices.

11. Sept. 2026, 23:06 UTC

Pfizer Inc shares are slightly higher in after-market hours, with no specific news identified. The broader market reacted to August's Consumer Price Index data.

9. Sept. 2026, 20:07 UTC

Pfizer Inc. is gaining during Wednesday's session despite mixed market reactions to its trademark deal with Novartis India, which may impact earnings.

8. Sept. 2026, 20:08 UTC

Pfizer shares are lower as the company announces a webcast featuring CEO Albert Bourla at the Morgan Stanley Healthcare Conference scheduled for September 2026.

4. Sept. 2026, 23:05 UTC

Pfizer Inc shares are lower in after-market hours, reflecting a slight decline since Friday's close amid mixed economic signals affecting market sentiment.

3. Sept. 2026, 23:01 UTC

Pfizer Inc. shares are lower in after-market hours, following a weak trading session and amid broader market softness from recent economic data on jobless claims.